Founded by Flagship Pioneering in 2020, Empress has built a proprietary product platform, called Chemilogics, to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificia...
Founded by Flagship Pioneering in 2020, Empress has built a proprietary product platform, called Chemilogics, to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to discover advanced starting points in endogenous drug-like molecules, helping clinicians to treat a wide range of serious unmet medical needs with small molecule drug candidates.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.